Phytochemical Characterization and TRPA1/TRPM8 Modulation Profile of the Cannabigerol-Rich Cannabis sativa L. Chemotype IV

Ernesto Gargiulo,Aniello Schiano Moriello,Emanuele Benetti,Luca Pagni,Lolita Arnoldi,Luciano De Petrocellis,Giuseppina Chianese,Rosa Maria Vitale,Orazio Taglialatela-Scafati
DOI: https://doi.org/10.1021/acs.jnatprod.3c00831
IF: 5.1
2024-02-26
Journal of Natural Products
Abstract:The first detailed phytochemical analysis of the cannabigerol (CBG)-rich chemotype IV of <i>Cannabis sativa</i> L. resulted in the isolation of the expected cannabigerolic acid/cannabigerol (CBGA/CBG) and cannabidiolic acid/cannabidiol (CBDA/CBD) and of nine new phytocannabinoids (<b>5</b>-<b>13</b>), which were fully characterized by HR-ESIMS and 1D and 2D NMR. These included mono- or dihydroxylated CBGA/CBG analogues, a congener with a truncated side chain (<b>10</b>), cyclocannabigerol B (<b>11</b>), and the CBD derivatives named cannabifuranols (<b>12</b> and <b>13</b>). Cyclocannabigerol B and cannabifuranols are characterized by a novel phytocannabinoid structural architecture. The isolated phytocannabinoids were assayed on the receptor channels TRPA1 and TRPM8, unveiling a potent dual TRPA1 agonist/TRPM8 antagonist profile for compounds <b>6</b>, <b>7</b>, and <b>14</b>. Chiral separation of the two enantiomers of <b>5</b> resulted in the discovery of a synergistic effect of the two enantiomers on TRPA1.
plant sciences,chemistry, medicinal,pharmacology & pharmacy
What problem does this paper attempt to address?